Country: Canada
Language: English
Source: Health Canada
BUSULFAN
APOTEX INC
L01AB01
BUSULFAN
60MG
SOLUTION
BUSULFAN 60MG
INTRAVENOUS
100
Prescription
ANTINEOPLASTIC AGENTS
Active ingredient group (AIG) number: 0103273002; AHFS:
APPROVED
2018-02-16
PRODUCT MONOGRAPH PR BUSULFAN INJECTION 6 MG/ML BUSULFAN PER VIAL STERILE SOLUTION ANTINEOPLASTIC APOTEX INC. DATE OF PREPARATION 150 SIGNET DRIVE February 15, 2018 WESTON, ONTARIO M9L 1T9 CONTROL NUMBER: 205892 PRODUCT MONOGRAPH Busulfan Injection 6 mg / mL BUSULFAN INJECTION (BUSULFAN) IS A POTENT CYTOTOXIC DRUG THAT RESULTS IN PROFOUND MYELOSUPPRESSION AT THE RECOMMENDED DOSAGE. IT SHOULD BE ADMINISTERED UNDER THE SUPERVISION OF A QUALIFIED PHYSICIAN WHO IS EXPERIENCED IN THE USE OF CANCER CHEMOTHERAPEUTIC AGENTS AND IN THE MANAGEMENT OF PATIENTS WITH SEVERE PANCYTOPENIA. APPROPRIATE MANAGEMENT OF THERAPY AND COMPLICATIONS IS ONLY POSSIBLE WHEN ADEQUATE DIAGNOSTIC AND TREATMENT FACILITIES ARE READILY AVAILABLE. ACTIONS AND CLINICAL PHARMACOLOGY Busulfan is a potent cytotoxic agent and a bifunctional alkylating agent. In aqueous media, release of the methanesulfonate group produces carbonium ions, which can alkylate DNA, thought to be an important biological mechanism for its cytotoxic effect. Current literature suggests that high AUC values (>1,500 μMol•min) may be associated with an increased risk of developing hepatic veno-occlusive disease and/or seizures. Mean C max , AUC, T 1/2 and plasma clearance are provided below for oral busulfan and Busulfan (See PHARMACOLOGY). PARAMETER ORAL BUSULFAN BUSULFAN C max (ng/mL) (range) (CV%) 870 (30%) 1,167 (12%) AUC (μMol•min) (CV%) 1,396 (24%) 1,156 (14%) T 1/2 (hr) (CV%) 3.55 (33%) 3.11 (10%) Plasma Clearance (mL/min) (CV%) 195 (27%) 182 (16%) Intravenous busulfan had a more consistent pharmacokinetic profile than oral busulfan among patients. Busulfan achieves concentrations in the cerebrospinal fluid approximately equal to those in plasma. Irreversible binding to plasma elements, primarily albumin, has been estimated to be 32.4 + 2.2%, which is consistent with the reactive electrophilic properties of this alkylator. Busulfan is predominately metabolized through conjugation with glutathione, both spontaneously and through glutathione S-transferase (GST). INDIC Read the complete document